AVT vs FSLY

AVT's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial health. The Graham Number suggests a defensive fair value of $59.95, implying the current price of $50.83 is slightly undervalued, though growth-based intrinsic value is much lower at $18.76. Profitability metrics are weak, with low margins and declining earnings, but the balance sheet shows strength via a solid current ratio and moderate leverage. Despite mixed signals, the stock appears fairly valued with moderate risks and limited near-term catalysts.

Fastly exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a massive 407.9% one-year price surge, the stock is trading at a significant premium with a Forward P/E of 80.91 and a current price ($29.46) nearly 84% above the analyst target price of $16.00. Heavy insider selling and a bearish technical trend suggest that the recent price action is speculative rather than fundamentally driven. The company remains unprofitable with a -19.50% profit margin, making the current valuation unsustainable.